---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-048428"
form_type: "8-K/A"
ticker: "DFTX"
cik: "0001813814"
company_name: "Definium Therapeutics, Inc."
filed_at: "2023-09-15T23:59:59+00:00"
generated_at: "2026-06-10T16:32:48.890213+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.0
calibrated_materiality_score: 0.0
confidence: "high"
source: SEC EDGAR
---

# Mind Medicine files 8-K/A to correct jurisdiction of incorporation to British Columbia

## Summary
- Corrects prior 8-K cover page jurisdiction from erroneous entry to British Columbia, Canada.
- Original Aug 14, 2023 8-K reported a loan agreement with K2 HealthVentures; this amendment does not alter that disclosure.
- No financial, operational, or liquidity impact; purely administrative correction.
- Company continues to trade on Nasdaq under symbol MNMD.

## SEC filing metadata
- accession: 0000950170-23-048428
- form_type: 8-K/A
- ticker: DFTX
- cik: 0001813814
- company_name: Definium Therapeutics, Inc.
- filed_at: 2023-09-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.0
- calibrated_materiality_score: 0.0
- confidence: high
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1813814/000095017023048428/0000950170-23-048428-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1813814/000095017023048428/mnmd-20230814.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-048428
- JSON: https://secwatch.observer/filing/0000950170-23-048428.json
- Plain text: https://secwatch.observer/filing/0000950170-23-048428.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.